Ahmed Moussa appointed Country Lead for Sanofi UK & Ireland

Reading, 13 January 2026. Ahmed Moussa has today been appointed as the new Sanofi Country Lead for the UK & Ireland, taking over from Rippon Ubhi.

In his new role, Ahmed will work as a key partner to Governments and health services to improve access to innovative medicines and vaccines for patients and the public. He will also be looking to champion the UK Life Sciences sector and help return it to international competitiveness as an attractive location for inward investment.

Ahmed brings nearly 18 years of tenure at Sanofi, including spearheading global Omnichannel transformation, and contributing significantly to different commercial roles in Greater Gulf region across Diabetes, Cardiovascular, Oncology, Specialty Care, and Market Access.

Ahmed Moussa

UK & Ireland Country Lead

"I'm truly honoured to be appointed to this role at a time of so many opportunities in the UK. The UK represents a unique healthcare landscape with distinctive challenges and remarkable potential, and I'm genuinely excited to be Sanofi's new voice here. With the support of our talented and dynamic teams, I'm committed to championing innovation and advocating for all patients to have access to the best health solutions available.”

Shannon Resetich

Head of Key Markets, Specialty Care

"Ahmed brings substantial experience and a proven track record of great leadership that positions him exceptionally well to take on this critical role in a market as significant as the UK. As an accomplished business leader, Ahmed has demonstrated the ability to effectively guide diverse teams and build meaningful partnerships that drive real impact. I look forward to witnessing how Ahmed's strategic vision and commitment to patients will continue to drive our mission forward to deliver innovative solutions across the UK and Ireland.” 

About Sanofi

We are an R&D-driven, AI-powered biopharma company with over 90,000 employees across 100 countries, committed to improving people's lives and delivering compelling growth. We are driven by one purpose: we chase the miracles of science to improve people's lives. Our team is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We focus on key therapeutic areas including immunology, oncology, rare diseases, vaccines, and general medicines. We provide potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.

Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY